Publication
Title
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer
Author
Language
English
Source (journal)
European journal of cancer. - Oxford, 1965 - 1981
Publication
Oxford : 2006
ISSN
0014-2964 [print]
1879-2995 [online]
Volume/pages
42:2(2006), p. 200-204
ISI
000235261300023
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 08.10.2008
Last edited 04.06.2017
To cite this reference